ISO 24190:2023
p
ISO 24190:2023
78060

Abstract

 Preview

This document provides guidance, a framework and a risk-based approach for the selection and validation of methods for rapid microbial detection in cellular therapeutic product manufacturing.

This document provides a flexible risk-based framework for the detection of microbial contamination in cellular therapeutic products and cellular intermediates.

This document provides general requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.

This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document is applicable to other cell-derived therapeutic product manufacturing.

This document focuses on rapid microbial test methods (RMTMs) used for both in-process and final product testing.

Viral testing in cellular therapeutic product manufacturing is not included in this document.


General information 

  •  :  Published
     : 2023-05
  •  : 1
     : 44
  •  : ISO/TC 276 Biotechnology
  •  :
    07.080 Biology. Botany. Zoology

Buy this standard

en
Format Language
std 1 166 PDF + ePub
std 2 166 Paper
  • CHF166

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)

Keep up to date with ISO

Sign up to our newsletter for the latest news, views and product information.